Home
Live
News
Create
Screeners
Insights
Mangalam Drugs & Organics
70.
19
-0.16
(-0.23%)
Market Cap
₹111.40 Cr
PE Ratio
-11.41
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.23%
1M
-6.58%
6M
-14.11%
1Y
-41.65%
5Y
-50.71%
View Company Insights
Latest news about Mangalam Drugs & Organics
Mangalam Drugs and Organics Receives NCLT Approval for Merger Scheme
4 days ago
Mangalam Drugs & Organics Limited (MDOL) received an NCLT order admitting a petition for a merger scheme involving Mangalam Laboratories Private Limited and Shri JB Pharma Private Limited. The petition was presented on September 23, 2025, with a final hearing scheduled for December 16, 2025. NCLT has directed notices to be issued to various statutory authorities, giving them 30 days to submit representations. MDOL will keep stock exchanges informed of further developments.
Manglam Group Launches ₹100 Crore Redevelopment Project in Mumbai's Borivali
Oct 06, 2025
Mangalam Drugs Shares Pledged by Shree Kishoriju Trading for Debt Security
Sep 06, 2025
Mangalam Drugs & Organics' Merger Scheme Receives Strong Backing from Unsecured Creditors
Aug 14, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation